Ginsenoside Rd protects SH-SY5Y cells against 1-methyl-4-phenylpyridinium induced injury

International Journal of Molecular Sciences

Volumn 16, Issue 7, 2015, Pages 14395-14408

  Liu, Yang ^a,b   Zhang, Ren Yu ^c   Zhao, Jun ^d   Dong, Zheng ^c   Feng, Dong Yun ^a   Wu, Rui ^a   Shi, Ming ^a   Zhao, Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 153rd Hospital of People s Liberation Army   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d 316th Hospital of PLA   (China)

Author keywords

Ginsenoside Rd; MPP+; Neuroprotection; Parkinson s disease; Reactive oxygen species; SH SY5Y

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATE; GINSENOSIDE RD; GLUTATHIONE PEROXIDASE; HOE 33342; LACTATE DEHYDROGENASE; MALONALDEHYDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE; ANTIOXIDANT; GINSENOSIDE; NEUROPROTECTIVE AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; MTT ASSAY; NEUROBLASTOMA CELL LINE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; UPREGULATION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; C57BL MOUSE; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; METABOLISM; MITOCHONDRION; MPTP POISONING; TUMOR CELL LINE;

PANAX GINSENG; PARKINSONIA;

1-METHYL-4-PHENYLPYRIDINIUM; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; DOPAMINERGIC NEURONS; ELECTRON TRANSPORT COMPLEX I; GINSENOSIDES; HUMANS; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MPTP POISONING; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES;

EID: 84933564727     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160714395     Document Type: Article

References (31)

1. Onyango, I.G. Mitochondrial dysfunction and oxidative stress in parkinson’s disease. Neurochem. Res. 2008, 33, 589–597
2. Perfeito, R.; Cunha-Oliveira, T.; Rego, A.C. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of parkinson disease—Resemblance to the effect of amphetamine drugs of abuse. Free Radic. Biol. Med. 2012, 53, 1791–1806
3. Hauser, D.N.; Hastings, T.G. Mitochondrial dysfunction and oxidative stress in parkinson’s disease and monogenic parkinsonism. Neurobiol. Dis. 2013, 51, 35–42
4. Macchi, B.; Paola, D.R.; Marino-Merlo, F.; Felice, M.R.; Cuzzocrea, S.; Mastino, A. Inflammatory and cell death pathways in brain and peripheral blood in parkinson’s disease. CNS Neurol. Disord. Drug Targets 2015, 14, 313–324
5. Yan, M.H.; Wang, X.; Zhu, X. Mitochondrial defects and oxidative stress in alzheimer disease and parkinson disease. Free Radic. Biol. Med. 2013, 62, 90–101
6. Ye, R.; Han, J.; Kong, X.; Zhao, L.; Cao, R.; Rao, Z.; Zhao, G. Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol. Pharm. Bull. 2008, 31, 1923–1927
7. Ye, R.; Li, N.; Han, J.; Kong, X.; Cao, R.; Rao, Z.; Zhao, G. Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci. Res. 2009, 64, 306–310
8. Ye, R.; Kong, X.; Yang, Q.; Zhang, Y.; Han, J.; Li, P.; Xiong, L.; Zhao, G. Ginsenoside Rd in experimental stroke: Superior neuroprotective efficacy with a wide therapeutic window. Neurochem. Int. 2011, 8, 515–525
9. Ye, R.; Yang, Q.; Kong, X.; Han, J.; Zhang, X.; Zhang, Y.; Li, P.; Liu, J.; Shi, M.; Xiong, L et al. Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem. Int. 2011, 58, 391–398
10. Ye, R.; Zhang, X.; Kong, X.; Han, J.; Yang, Q.; Zhang, Y.; Chen, Y.; Li, P.; Liu, J.; Shi, M et al. Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience 2011, 178, 169–180
11. Liu, X.; Xia, J.; Wang, L.; Song, Y.; Yang, J.; Yan, Y.; Ren, H.; Zhao, G. Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: A randomized, double-blind, placebo-controlled, phase II multicenter trial. Eur. J. Neurol. 2009, 16, 569–575
12. Gonzalez-Polo, R.A.; Soler, G.; Rodriguezmartin, A.; Moran, J.M.; Fuentes, J.M. Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants. Cell Biol. Int. 2004, 28, 373–380
13. Zhang, X.; Shi, M.; Ye, R.; Wang, W.; Liu, X.; Zhang, G.; Han, J.; Zhang, Y.; Wang, B.; Zhao, J.; et al. Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia. Neurochem. Res. 2014, 39, 1363–1373
14. Zhai, A.; Zhu, X.; Wang, X.; Chen, R.; Wang, H. Secalonic acid a protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+)-induced cell death via the mitochondrial apoptotic pathway. Eur. J. Pharmacol. 2013, 713, 58–67
15. Perier, C.; Bove, J.; Wu, D.C.; Dehay, B.; Choi, D.K.; Jackson-Lewis, V.; Rathke-Hartlieb, S.; Bouillet, P.; Strasser, A.; Schulz, J.B et al. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental parkinson’s disease. Proc. Natl. Acad. Sci. USA 2007, 104, 8161–8166
16. Keeney, P.M.; Xie, J.; Capaldi, R.A.; Bennett, J.P., Jr. Parkinson’s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 2006, 26, 5256–5264
17. Isobe, C.; Abe, T.; Terayama, Y. Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′- deoxyguanosine in the cerebrospinal fluid of patients with living parkinson’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci. Lett. 2010, 469, 159–163
18. Perier, C.; Tieu, K.; Guegan, C.; Caspersen, C.; Jackson-Lewis, V.; Carelli, V.; Martinuzzi, A.; Hirano, M.; Przedborski, S.; Vila, M. Complex I deficiency primes bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc. Natl. Acad. Sci. USA 2005, 102, 19126–19131
19. Erfani, S.; Khaksari, M.; Oryan, S.; Shamsaei, N.; Aboutaleb, N.; Nikbakht, F. Nampt/PBEF/visfatin exerts neuroprotective effects against ischemia/reperfusion injury via modulation of Bax/Bcl-2 ratio and prevention of caspase-3 activation. J. Mol. Neurosci. 2015, 56, 237–243
20. Wang, G.; Pan, J.; Chen, S.D. Kinases and kinase signaling pathways: Potential therapeutic targets in parkinson’s disease. Prog. Neurobiol. 2012, 98, 207–221
21. Wada, A.; Yokoo, H.; Yanagita, T.; Kobayashi, H. Lithium: Potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J. Pharmacol. Sci. 2005, 99, 307–321
22. Timmons, S.; Coakley, M.F.; Moloney, A.M.; O’Neill, C. Akt signal transduction dysfunction in parkinson’s disease. Neurosci. Lett. 2009, 467, 30–35
23. Kim, S.R.; Chen, X.; Oo, T.F.; Kareva, T.; Yarygina, O.; Wang, C.; During, M.; Kholodilov, N.; Burke, R.E. Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration. Ann. Neurol. 2011, 70, 110–120
24. Hu, S.; Han, R.; Mak, S.; Han, Y. Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. J. Ethnopharmacol. 2011, 135, 34–42
25. Chen, X.C.; Zhou, Y.C.; Chen, Y.; Zhu, Y.G.; Fang, F.; Chen, L.M. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol. Sin. 2005, 26, 56–62
26. Radad, K.; Gille, G.; Moldzio, R.; Saito, H.; Ishige, K.; Rausch, W.D. Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells. J. Neural Trans. 2004, 111, 37–45
27. Shi, C.; Zheng, D.D.; Fang, L.; Wu, F.; Kwong, W.H.; Xu, J. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/AKT. Biochim. Biophys. Acta 2012, 1820, 453–460
28. Ni, N.; Liu, Q.; Ren, H.; Wu, D.; Luo, C.; Li, P.; Wan, J.B.; Su, H. Ginsenoside rb1 protects rat neural progenitor cells against oxidative injury. Molecules 2014, 19, 3012–3024
29. Zhao, J.; Bai, Y.; Zhang, C.; Zhang, X.; Zhang, Y.X.; Chen, J.; Xiong, L.; Shi, M.; Zhao, G. Cinepazide maleate protects pc12 cells against oxygen-glucose deprivation-induced injury. Neurol. Sci. 2014, 35, 875–881
30. Cen, J.; Liu, L.; He, L.; Liu, M.; Wang, C.J.; Ji, B.S. N1-(quinolin-2-ylmethyl)butane-1,4-diamine, a polyamine analogue, attenuated injury in in vitro and in vivo models of cerebral ischemia. Int. J. Dev. Neurosci. 2012, 30, 584–595
31. Shi, M.; Du, F.; Liu, Y.; Li, L.; Cai, J.; Zhang, G.F.; Xu, X.F.; Lin, T.; Cheng, H.R.; Liu, X.D. et al. Glial cell-expressed mechanosensitive channel TRPV4 mediates infrasound-induced neuronal impairment. Acta Neuropathol. 2013, 126, 725–739.